​

Funding Round

Venture Round - Truvian Sciences

Venture Round - Truvian Sciences

Investment Firm

Overview

Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.

Announced Date

Jul 17, 2024

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

GreatPoint Ventures

GreatPoint Ventures

GreatPoint Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorMedical Excellence Capital
Participant InvestorTao Capital Partners
Participant InvestorDNS Capital
Participant Investor7wire Ventures
Participant InvestorGreatPoint Ventures

Round Details and Background

Truvian Sciences raised $74000000 on 2024-07-17 in Venture Round

Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 20, 2019
Series B - Truvian Sciences
4-27.1M
Sep 28, 2015
Seed Round - Truvian Sciences
-2.0M
Feb 24, 2021
Series C - Truvian Sciences
9-105.0M
Jul 17, 2024
Venture Round - Truvian Sciences
7-74.0M

Recent Activity

There is no recent news or activity for this profile.